换一批摘要Gene editing nucleases(GENs),represented by CRISPR/Cas9,have become major tools in biomedical research and offer potential cures for many human diseases.Gene editing therapy(GETx)studies in animal models targeting genes such as proprotein convertase subtilisin/kexin type 9(PCSK9),apolipoprotein C3(APOC3),angiopoietin Like 3(ANGPTL3)and inducible degrader of the low-density lipoprotein receptor(IDOL)have demonstrated the benefits and advantages of GETx in managing atherosclerosis.Here we present our views on this brand new therapeutic option for cardiovascular diseases(CVD).
更多相关知识
栏目名称
DOI
10.1515/mr-2021-0010
发布时间
2023-08-02（万方平台首次上网日期，不代表论文的发表时间）
- 浏览2
- 被引1
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
